Oncology/Hematology > Other Cancers — Statistics support noninferiority versus more toxic chemotherapy, but results far from definitive by Charles Bankhead, Senior Editor, MedPage Today February 2, 2024 Neoadjuvant trabectedin (Yondelis)….
Satisfying Coverage > GICS — Lutetium dotatate decreases PFS danger by 72% in randomized trial by Charles BankheadSenior Editor, MedPage Today January 20, 2024 SAN FRANCISCO– Adding a radioligand to….